Earnings Call · Q2 FY2024·2024-08-10

Q2 24EPS -4.00%·Rev n/aQ1 24EPS +12.00%·Rev n/aQ4 23EPS +25.00%·Rev n/aQ3 23EPS +24.14%·Rev n/a⚠ consensus missing

Cardiff Oncology, Inc. CRDF

Kiki Patel — Host/Investor Relations

Mark Erlander — Chief Executive Officer

Jamie Levine — Chief Financial Officer

+11.7%1d on move date+11.3% vs SPY3d+5.6%5d+12.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRDF calls or request research access.

More CRDF calls Browse calls Request research access